Scientifically preventing and treating diabetic retinopathy

( views:132, downloads:0 )
Author:
JIANG Yan-rong()
TAO Yong()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 15, Issue 07, 2007
DOI:
Key Word:

Abstract´╝Ü

  • [1]Xu L,Wang Y,Li Y,et al.Causes of blindness and visual impairment in urban and rural areas in Beijing:the Beijing Eye Study.Ophthalmology,2006,113:1134.e1-11.
  • [2]Negi A,Vernon SA.An overview of the eye in diabetes.J R Soc Med,2003,96:266-272.
  • [3]Tong L,Vernon SA,Kiel W,et al.Association of macular involvement with proliferative retinopathy in type 2 diabetes.Diabet Med,2001,18:388-394.
  • [4]Kissebah AH,Kohner EM,Lewis B,et al.Plasma lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy.Lancet,1975,1:1104-1108.
  • [5]Moloney JB,Drury MI.The effect of pregnancy on the natural course of diabetic retinopathy.Am J Ophthalmol,1982,93:745-756.
  • [6]Cruickshanks KJ,Moss SE,Klein R,et al.Physical activity and the risk of progression of retinopathy or the development of proliferative retinopathy.Ophthalmology,1995,102:1177-1182.
  • [7]The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med,1993,329:977-986.
  • [8]UK Prospective Diabetes Study (UKPDS) Group.Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998,352:837-853.
  • [9]UK Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38.BMJ,1998,317:703-713.
  • [10]UK Prospective Diabetes Study Group.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 39.UK Prospective Diabetes Study Group.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 39.BMJ,1998,317:713-720.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn